Summarized by Masters of Longevity from Longevity Technology.
Preclinical mouse study found limited benefits from the probiotic plus semaglutide.

Key Takeaways
- An engineered probiotic was tested in mice with semaglutide.
- Results were mixed and showed only a few positive signals.
- The company plans a repeat study at a lower drug dose.



